Allergy & Immunology CME

Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Translating Science to Transform Clinical Practice: How MEK Inhibitors Are Changing the Treatment Landscape of NF1 and NF1-Associated Tumors
July 15, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Demystifying the Role of Incretin-Based Weight-Loss Pharmacotherapy: A Patient-Centered Approach to Overcoming Barriers and Addressing Underlying Causes of Obesity
Donna H. Ryan, MD, FTOS
July 15, 2021
Credits: 1.00 CME / MOC / CC / NCPD
Medical Learning Institute, Inc.
Marking New Milestones With Immunotherapy in Locally Advanced and Early Lung Cancer: Latest Data Informing Best Practices for Multimodal Management of Stage I-III NSCLC
Jamie E. Chaft, MD
July 12, 2021
Credits: 1.00 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
A New Treatment Era for Light Chain Amyloidosis: Interprofessional Lessons From a Center of Excellence
Suzanne Lentzsch, MD, PhD
July 9, 2021
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Gaining New Ground With Immunotherapy in the Management of Early and Advanced Gastrointestinal Cancers: Translating Progress Into Clinical Practice in Gastric, Esophageal, GEJ, and Colorectal Cancers
Jaffer A. Ajani, MD / Ian Chau, MD, FRCP
July 9, 2021
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Building Better Models for Melanoma Care: Continued Progress With Immunotherapy in Resectable and Unresectable Disease
Jason J. Luke, MD, FACP / Geoffrey T. Gibney, MD
July 7, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Evaluating the Evidence and Parsing the Practicalities of Therapeutic Choices in Advanced and Early HR+ Breast Cancer: Expert Perspectives on CDK4 and 6 Inhibitors and Other Novel Agents
Sara M. Tolaney, MD, MPH
July 7, 2021
Credits: 1.00 CME
Medical Learning Institute, Inc.
Going With Your Gut: Targeting Long-Term Weight Loss With Current and Emerging Incretin-Based Pharmacotherapy
Christopher D. Still, DO, FACP, FTOS / Alan C. Wittgrove, MD, FASMBS, FACS
July 7, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Innovation at Warp Speed for Multiple Myeloma: Tumor Board Insights on State-of-the-Art Care
Nina Shah, MD
July 7, 2021
Credits: 1.50 CME / MOC / NCPD
Medical Learning Institute, Inc.
The Expanding Advanced Ovarian Cancer Treatment Palette: Candid Conversations on Bringing PARP Inhibitors Into Clinical Practice
Deborah K. Armstrong, MD
July 6, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Making the Most of Treatment Advances in SCLC: New Standards, Practicalities of Care, and Hope on the Horizon
Jacob Sands, MD
July 5, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Clinical Consults on Modern AML Therapy: Where Precision Care Meets Potent Therapeutics
Gail J. Roboz, MD
July 5, 2021
Credits: 1.50 CME / MOC
PVI, PeerView Institute for Medical Education
Rethinking the Care of Renal Cell Carcinoma: Expert Perspectives on Novel Agents, Combinations, and Sequencing Therapy
Toni K. Choueiri, MD
July 5, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Pushing Therapeutic Boundaries in CLL: The Convergence of Targeted Therapy, Novel Combinations, and Precision Medicine in Patient Care
Matthew S. Davids, MD, MMSc
July 2, 2021
Credits: 1.50 CME / MOC / NCPD
Medical Learning Institute, Inc.
Making Progress in Early and Advanced HER2-Positive Breast Cancer: Leveraging HER2-Targeted Therapies and Modern Care Principles to Improve Clinical Outcomes and Health Equity
Sara Hurvitz, MD
July 2, 2021
Credits: 1.50 CME / MOC / CC
Medical Learning Institute, Inc.
Expanding the Benefits of Checkpoint Inhibitors and Targeted Agents in the Treatment Arsenal for Triple-Negative Breast Cancer
Joyce O’Shaughnessy, MD
July 2, 2021
Credits: 1.25 CME / MOC
Medical Learning Institute, Inc.
Achieving Therapeutic Innovation in ALL: Insights on Modern Asparaginase Compounds in Pediatric, AYA, and Adult Patients
Nicola Gökbuget, MD
June 30, 2021
Credits: 1.50 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
New Standards for CLL Care With BTK Inhibitors: Using Evidence to Make Personalized Treatment Choices
William G. Wierda, MD, PhD
June 29, 2021
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Teaming Up to Overcome Challenges in the Diagnosis and Management of Noninfectious Uveitis: Enhancing Multidisciplinary Care in the Biologic Therapy Era
James T. Rosenbaum, MD
June 28, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
The Dawn of a New Era: Recent Advances in the Pharmacologic Management of Idiopathic Hypersomnia
R. Robert Auger, MD, FAASM, FAPA, DABPN
June 25, 2021
Credits: 1.50 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Innovative Immunotherapy in Advanced Basal Cell Carcinoma: Evolving Science, Key Clinical Evidence, and Implications for Multidisciplinary Management
Karl D. Lewis, MD
June 25, 2021
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
New and Emerging Therapeutic Strategies in Bladder Cancer: Updates in Early-Stage Disease and Beyond
Matthew D. Galsky, MD
June 23, 2021
Credits: 1.00 CME
Penn State College of Medicine
Management of Hyperlipidemia in the Family Medicine Setting: Diagnosis, Management, and the Role of Emerging Lipid-Lowering Therapies
James A. Underberg, MD, MS, FACPM, FACP, FNYAM, FASPC, FNLA
June 22, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Managing Motor Complications in Parkinson’s Disease: Evaluating the Role of On-Demand Therapies for “Off” Episodes
Stuart H. Isaacson, MD
June 22, 2021
Credits: 1.00 CME
Medical Learning Institute, Inc.
Addressing the Unmet Needs of Patients With Moderate to Severe Psoriasis: A Visual Exploration of Disease Pathogenesis and the Clinical Potential of Targeting the TYK2 Pathway as a Novel Nonbiologic Oral Therapeutic Option
Andrew Blauvelt, MD, MBA
June 21, 2021
Credits: 0.25 NCPD
Medical Learning Institute, Inc.
Leading the Way in Multiple Myeloma: Nurse Perspectives on Recent Developments With Novel Therapeutics
Beth Faiman, PhD, RN, MSN, ANP-BC, AOCN, FAAN
June 21, 2021
Credits: 0.50 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Beyond TNF Inhibitors: Latest and Emerging Evidence on Novel Cytokine-Modulating Strategies in the Treatment of Moderate to Severe Psoriasis
April W. Armstrong, MD, MPH
June 17, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Envisioning the Future of Emerging Nonfactor Therapies in Hemophilia A and B: The Art and Science of RNA Interference
Steven W. Pipe, MD
June 16, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
A Visual Exploration of Antisense Oligonucleotide Therapies in Amyotrophic Lateral Sclerosis
Jinsy A. Andrews, MD, MSc, FAAN
June 8, 2021
Credits: 1.25 CME / NCPD
Medical Learning Institute, Inc.
HIF-PH Inhibitors: An Emerging Strategy for Managing Anemia in Patients With Chronic Kidney Disease
Rajiv Agarwal, MD, MS
June 3, 2021

Pages

Education Collections